These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pancreas-specific immune-related adverse events in patients with lung cancer: a case series study.
    Author: Jia L, Yuequan S, Jian F, Hongmin L, Yongjie S, Xiaoyan L, Minjiang C, Yan X, Mengzhao W.
    Journal: Immunotherapy; 2024; 16(11):715-722. PubMed ID: 38888461.
    Abstract:
    Immune-related adverse events (irAEs) are one of the key concerns in cancer patients treated with immune checkpoint inhibitors (ICIs). Among the various irAEs, pancreas-specific irAE is a rare but special one with a variety of manifestations, such as pancreatic enzymes elevation, pancreatitis as well as diabetes. The current study reported 22 pancreas-specific irAEs in 21 patients with lung cancer, including pancreatic injury in 13 patients, pancreatitis in four patients and diabetes mellitus in five patients. [Box: see text].
    [Abstract] [Full Text] [Related] [New Search]